ImageneBio (IMA) Change in Account Payables (2020 - 2025)
ImageneBio (IMA) posted Change in Account Payables of -$1.8 million for Q3 2025, up 0.88% sequentially from -$1.8 million in Q2 2025, and down 13.69% YoY from -$2.1 million in Q3 2024.
ImageneBio (IMA) Change in Account Payables (2020 - 2025) Analysis & Trends
ImageneBio has reported Change in Account Payables for 6 years, with the latest figure at -$1.8 million in Q3 2025.
- Quarterly Change in Account Payables fell 13.69% year-over-year to -$1.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$1.1 million (up 73.0% YoY) and the FY2024 annual result came in at -$1.2 million, up 59.27% from the prior year.
- Change in Account Payables rose to -$1.8 million in Q3 2025 per IMA's latest filing, from -$1.8 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.4 million in Q1 2025 and troughed at -$1.9 million in Q4 2023.
- A 5-year average of -$323578.9 and a median of -$157000.0 in 2024 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 16550.0% in 2023, down 2115.29% in 2023.
- Over 5 years, Change in Account Payables stood at $455000.0 in 2021, then plunged by 118.68% to -$85000.0 in 2022, then slumped by 2115.29% to -$1.9 million in 2023, then soared by 156.66% to $1.1 million in 2024, then tumbled by 268.13% to -$1.8 million in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$1.8 million, -$1.8 million, and $1.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.79 Mn |
| Sep 30, 2025 | -1.79 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.43 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | -1.58 Mn |
| Sep 30, 2024 | -1.58 Mn |
| Jun 30, 2024 | -501,000.00 |
| Jun 30, 2024 | -501,000.00 |
| Mar 31, 2024 | -157,000.00 |
| Mar 31, 2024 | -157,000.00 |
| Dec 31, 2023 | -1.88 Mn |
| Dec 31, 2023 | -1.88 Mn |
| Sep 30, 2023 | -666,000.00 |
| Sep 30, 2023 | -666,000.00 |
| Jun 30, 2023 | -987,000.00 |
| Jun 30, 2023 | -987,000.00 |